FGP
COV

Foyston, Gordon, & Payne’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Foyston, Gordon, & Payne’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-158,286
Closed -$16.2M – 76
2014
Q4 		$16.2M Buy
158,286
+28,109
+22% +$2.7M 2.31% 18
2014
Q3 		$11.3M Sell
130,177
-135,030
-51% -$12M 1.62% 25
2014
Q2 		$23.9M Sell
265,207
-28,515
-10% -$2.13M 3.04% 10
2014
Q1 		$21.6M Buy
293,722
+20,312
+7% +$1.42M 2.67% 9
2013
Q4 		$18.6M Sell
273,410
-12,283
-4% -$799K 2.31% 13
2013
Q3 		$17.4M Buy
+285,693
New +$17.4M 2.27% 17

Foyston, Gordon, & Payne's COV Position: Q1 2015 in Review

Foyston, Gordon, & Payne sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 158,286 shares — an estimated $16.2M sold.

Foyston, Gordon, & Payne first reported a position in COV in Q3 2013 and held it in 6 quarters. The position peaked at $23.9M in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

  • Foyston, Gordon, & Payne reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
  • Foyston, Gordon, & Payne sold 158,286 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $16.2M.
  • Foyston, Gordon, & Payne first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2013 and held it in 6 quarters.
  • Foyston, Gordon, & Payne's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $23.9M in Q2 2014.
  • 1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2015, filed 15 May 2015.